参考文献/References:
[1] Huxley RR,Lopez FL,Folsom AR,et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors:the Atherosclerosis Risk in Communities (ARIC) study[J]. Circulation,2011,123 (14):1501-1508.
[2] Stevens SL,Wood S,Koshiaris C,et al. Blood pressure variability and cardiovascular disease:systematic review and meta-analysis[J]. BMJ,2016,354:i4098.
[3] Parati G,Stergiou GS,Dolan E,et al. Blood pressure variability:clinical relevance and application[J]. J Clin Hypertens (Greenwich),2018,20(7):1133-1137.
[4] Parati G,Ochoa JE,Lombardi C,et al. Assessment and interpretation of blood pressure variability in a clinical setting[J]. Blood Press,2013,22(6):345-354.
[5] Feber J,Litwin M. Blood pressure(BP) assessment-from BP level to BP variability[J]. Pediatr Nephrol,2016,31(7):1071-1079.
[6] Bilo G,Giglio A,Styczkiewicz K,et al. A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall[J]. J Hypertens,2007,25(10):2058-2066.
[7] Sogunuru GP,Kario K,Shin J,et al. Morning surge in blood pressure and blood pressure variability in Asia:Evidence and statement from the HOPE Asia Network[J]. J Clin Hypertens (Greenwich),2019,21(2):324-334.
[8] Lee SR,Choi EK,Han KD,et al. Effect of the variability of blood pressure,glucose level,total cholesterol level,and body mass index on the risk of atrial fibrillation in a healthy population[J]. Heart Rhythm,2020,17(1):12-19.
[9] Murakami S,Otsuka K,Kubo Y,et al. Weekly variation of home and ambulatory blood pressure and relation between arterial stiffness and blood pressure measurements in community-dwelling hypertensives[J]. Clin Exp Hypertens,2005,27(2-3):231-239.
[10] Rothwell PM,Howard SC,Dolan E,et al. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke[J]. Lancet Neurol,2010,9(5):469-480.
[11] Stergiou GS,Palatini P,Modesti PA,et al. Seasonal variation in blood pressure:evidence,consensus and recommendations for clinical practice. Consensus statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability[J]. J Hypertens,2020,38(7):1235-1243.
[12] Tang X,Dworkin BR. The dmNTS is not the source of increased blood pressure variability in baroreflex denervated rats[J]. Auton Neurosci,2009,148(1-2):21-27.
[13] Seccia TM,Caroccia B,Adler GK,et al. Arterial hypertension,atrial fibrillation,and hyperaldosteronism:the triple trouble[J]. Hypertension,2017,69(4):545-550.
[14] Coulson JM. The relationship between blood pressure variability and catecholamine metabolites:a pilot study[J]. J Hum Hypertens,2015,29(1):50-52.
[15] Lee SR,Choi YJ,Choi EK,et al. Blood pressure variability and incidence of new-onset atrial fibrillation:a nationwide population-based study[J]. Hypertension,2020,75(2):309-315.
[16] Olbers J,Gille A,Ljungman P,et al. High beat-to-beat blood pressure variability in atrial fibrillation compared to sinus rhythm[J]. Blood Press,2018,27(5):249-255.
[17] 赵宏,李萍. 原发性高血压患者血压变异性与房颤关系研究[J]. 临床心电学杂志,2021,30(2):116-120.
[18] 王海军,司全金,李开亮,等. 老年原发性高血压患者血压变异性对新发心房颤动的影响[J]. 中华老年心脑血管病杂志,2017,19(3):228-231.
[19] 张康,单丽君. 老年原发性高血压患者血压变异性新发心房颤动影响分析[J]. 中国高等医学教育,2018(11):137-138.
[20] Mahfouz RA,El-Shetry M,Frere A,et al. Blood pressure variability and atrial fibrillation in patients with acute ST segment elevation myocardial infarction:the relation with left atrial electromechanical delay —A 1-year follow-up study[J]. Pulse(Basel),2020,8(1-2):57-65.
[21] 刘英,李志业,张强,等 .血压变异性与原发性高血压患者心房颤动的关系[J]. 郑州大学学报(医学版),2019,54(1):126-130.
[22] Kario K,Hoshide S,Uchiyama K,et al. Dose timing of an angiotensin Ⅱ receptor blocker/calcium channel blocker combination in hypertensive patients with paroxysmal atrial fibrillation[J]. J Clin Hypertens (Greenwich),2016,18(10):1036-1044.
[23] Cipollini F,Arcangeli E,Seghieri G. Left atrial dimension is related to blood pressure variability in newly diagnosed untreated hypertensive patients[J]. Hypertens Res,2016,39(8):583-587.
[24] Norioka N,Iwata S,Ito A,et al. Greater nighttime blood pressure variability is associated with left atrial enlargement in atrial fibrillation patients with preserved ejection fraction[J]. Hypertens Res,2018,41(8):614-621.
[25] Shin SH,Jang JH,Baek YS,et al. Relation of blood pressure variability to left ventricular function and arterial stiffness in hypertensive patients[J]. Singapore Med J,2019,60(8):427-431.
[26] Park JS,Shin JH,Park JB,et al. Relationship between arterial stiffness and variability of home blood pressure monitoring[J]. Medicine (Baltimore),2020,99(30):e21227.
[27] Tadic M,Cuspidi C,Ilic I,et al. The relationship between blood pressure variability,obesity and left atrial phasic function in hypertensive population[J]. Int J Cardiovasc Imaging,2016,32(4):603-612.
[28] Lim DJ,Ambale-Ventakesh B,Ostovaneh MR,et al. Change in left atrial function predicts incident atrial fibrillation:the Multi-Ethnic Study of Atherosclerosis[J]. Eur Heart J Cardiovasc Imaging,2019,20(9):979-987.
[29] Chung GE,Park HE,Lee H,et al. Clinical significance of increased arterial stiffness associated with atrial fibrillation,according to Framingham risk score[J]. Sci Rep,2021,11(1):4955.
[30] Liu Y,Lin Y,Zhang MM,et al. The relationship of plasma renin,angiotensin,and aldosterone levels to blood pressure variability and target organ damage in children with essential hypertension[J]. BMC Cardiovasc Disord,2020,20(1):296.
[31] Ozkayar N,Dede F,Akyel F,et al. Relationship between blood pressure variability and renal activity of the renin-angiotensin system[J]. J Hum Hypertens,2016,30(5):297-302.
[32] 蔡晓琪. 高血压患者血管超负荷指数与心血管结构及功能的关系[D]. 福建医科大学,2013.
[33] Linz D,Ukena C,Mahfoud F,et al. Atrial autonomic innervation:a target for interventional antiarrhythmic therapy?[J]. J Am Coll Cardiol,2014,63(3):215-224.
[34] Proietti M,Romiti GF,Olshansky B,et al. Systolic blood pressure visit-to-visit variability and major adverse outcomes in atrial fibrillation:the AFFIRM Study (atrial fibrillation follow-up investigation of rhythm management)[J]. Hypertension,2017,70(5):949-958.
[35] Kodani E,Inoue H,Atarashi H,et al. Impact of blood pressure visit-to-visit variability on adverse events in patients with nonvalvular atrial fibrillation:subanalysis of the J-RHYTHM registry[J]. J Am Heart Assoc,2021,10(1):1-13.
[36] Kamioka M,Kaneshiro T,Hijioka N,et al. Visit-to-visit blood pressure variability predicts atrial fibrillation recurrence after pulmonary vein isolation in patients with hypertension and atrial fibrillation[J]. Circ Rep,2021,3(4):187-193.
[37] Sare GM,Ali M,Shuaib A,et al. Relationship between hyperacute blood pressure and outcome after ischemic stroke:data from the VISTA collaboration[J]. Stroke,2009,40(6):2098-2103.
[38] Soliman EZ,Rahman AF,Zhang ZM,et al. Effect of intensive blood pressure lowering on the risk of atrial fibrillation[J]. Hypertension,2020,75(6):1491-1496.
[39] Yang K,Wang Y,Ding Y,et al. Valsartan chronotherapy reverts the non-dipper pattern and improves blood pressure control through mediation of circadian rhythms of the renin-angiotensin system in spontaneous hypertension rats[J]. Chronobiol Int,2019,36(8):1058-1071.
[40] Li LY,Lou Q,Liu GZ,et al. Sacubitril/valsartan attenuates atrial electrical and structural remodelling in a rabbit model of atrial fibrillation[J]. Eur J Pharmacol,2020,881:173120.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(4):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(4):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(4):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(4):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(4):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(4):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(4):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(4):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(4):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]